Results 171 to 180 of about 786,681 (194)

Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis. [PDF]

Sci Rep
Huang YJ, Wang JS, Chen CH, Lee SW, Chang CH, Liao SC, Peng YC, Lee TY, Li TC.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres, Filippo Miglior, Terri Lynn Shigle   +2 more
exaly  

The importance of immunization in cancer prevention, treatment, and survivorship

Ca-A Cancer Journal for Clinicians, 2017
Ted Gansler, Christopher R Flowers, Saad B Omer   +2 more
exaly  

Disparities in liver cancer occurrence in the United States by race/ethnicity and state

Ca-A Cancer Journal for Clinicians, 2017
Farhad Islami, Rebecca L Siegel, Ahmedin Jemal   +2 more
exaly  

Cancer‐related risk factors and preventive measures in US Hispanics/Latinos

Ca-A Cancer Journal for Clinicians, 2012
Priti Bandi
exaly  

Therapeutic strategies for hepatitis B virus infection: towards a cure

Nature Reviews Drug Discovery, 2019
Antonio Bertoletti, Fabien Zoulim, Jinlin Hou   +2 more
exaly  

Hepatitis C therapeutics: current status and emerging strategies

Nature Reviews Drug Discovery, 2002
Ding-wei Ye
exaly